These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35327013)

  • 1. A Mobile App for Triangulating Strategies in Phosphate Education Targeting Patients with Chronic Kidney Disease in Malaysia: Development, Validation, and Patient Acceptance.
    Teong LF; Khor BH; Radion Purba K; Gafor AHA; Goh BL; Bee BC; Yahya R; Bavanandan S; Ng HM; Sahathevan S; Narayanan SS; Daud ZAM; Khosla P; Karupaiah T
    Healthcare (Basel); 2022 Mar; 10(3):. PubMed ID: 35327013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a Nutritional Mobile Application for Management of Hyperphosphatemia in Patients on Hemodialysis: A Multicenter Open-Label Randomized Clinical Trial.
    Teong LF; Khor BH; Ng HM; Sahathevan S; Purba KR; Narayanan SS; Gafor AHA; Goh BL; Bee BC; Yahya R; Bavanandan S; Wahab Z; Mazlan SA; Chinna K; Morad Z; Daud ZAM; Karupaiah T
    J Pers Med; 2022 Jun; 12(6):. PubMed ID: 35743746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malay Version of the mHealth App Usability Questionnaire (M-MAUQ): Translation, Adaptation, and Validation Study.
    Mustafa N; Safii NS; Jaffar A; Sani NS; Mohamad MI; Abd Rahman AH; Mohd Sidik S
    JMIR Mhealth Uhealth; 2021 Feb; 9(2):e24457. PubMed ID: 33538704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
    Copland M; Komenda P; Weinhandl ED; McCullough PA; Morfin JA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S24-S32. PubMed ID: 27772640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of dietary phosphate restriction in chronic kidney disease.
    Elder GJ; Malik A; Lambert K
    Nephrology (Carlton); 2018 Dec; 23(12):1107-1115. PubMed ID: 29064141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary education approach to optimize phosphate control among hemodialysis patients.
    Chan MW; Cheah HM; Mohd Padzil MB
    Int J Clin Pharm; 2019 Oct; 41(5):1282-1289. PubMed ID: 31302884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset model.
    Ramakrishnan K; Braunhofer P; Newsome B; Lubeck D; Wang S; Deuson J; Claxton AJ
    Adv Ther; 2014 Dec; 31(12):1272-86. PubMed ID: 25479935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Individualized Dietary Phosphate Control Program With a Smartphone Application in Hemodialysis Patients in Taiwan.
    Chiang YC; Chang YP; Lin SC; Lin C; Hsu PH; Hsu YJ; Wu TJ
    Biol Res Nurs; 2021 Jul; 23(3):375-381. PubMed ID: 33251815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobile Apps for the Care Management of Chronic Kidney and End-Stage Renal Diseases: Systematic Search in App Stores and Evaluation.
    Siddique AB; Krebs M; Alvarez S; Greenspan I; Patel A; Kinsolving J; Koizumi N
    JMIR Mhealth Uhealth; 2019 Sep; 7(9):e12604. PubMed ID: 31486408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status.
    Lopes AA; Tong L; Thumma J; Li Y; Fuller DS; Morgenstern H; Bommer J; Kerr PG; Tentori F; Akiba T; Gillespie BW; Robinson BM; Port FK; Pisoni RL
    Am J Kidney Dis; 2012 Jul; 60(1):90-101. PubMed ID: 22385781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mobile App to Support Self-management of Chronic Kidney Disease: Development Study.
    Markossian TW; Boyda J; Taylor J; Etingen B; Modave F; Price R; Kramer HJ
    JMIR Hum Factors; 2021 Dec; 8(4):e29197. PubMed ID: 34914614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of education on low-phosphate diet and phosphate binder intake to control serum phosphate among maintenance hemodialysis patients: A randomized controlled trial.
    Lim E; Hyun S; Lee JM; Kim S; Lee MJ; Lee SM; Oh YS; Park I; Shin GT; Kim H; Morisky DE; Jeong JC
    Kidney Res Clin Pract; 2018 Mar; 37(1):69-76. PubMed ID: 29629279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of Adoption of a Mobile App to Support Patient Self-Management of Diabetes and Hypertension in a Federally Qualified Health Center: Interview Analysis of Staff and Patients in a Failed Randomized Trial.
    Thies K; Anderson D; Cramer B
    JMIR Hum Factors; 2017 Oct; 4(4):e24. PubMed ID: 28974481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A service review to assess if innovative intensive phosphate dietary education can help reduce phosphate levels to the recommended range in a hemodialysis population.
    Duff EA; Chawke FM
    Hemodial Int; 2017 Oct; 21 Suppl 2():S22-S26. PubMed ID: 29064180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily dietary phosphorus intake variability and hemodialysis patient adherence to phosphate binder therapy.
    Tao X; Zhang H; Yang Y; Zhang C; Wang M
    Hemodial Int; 2019 Oct; 23(4):458-465. PubMed ID: 31328873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperphosphataemia: treatment options.
    Malberti F
    Drugs; 2013 May; 73(7):673-88. PubMed ID: 23625273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Goal-Directed Design to Create a Mobile Health App to Improve Patient Compliance With Hypertension Self-Management: Development and Deployment.
    Duan H; Wang Z; Ji Y; Ma L; Liu F; Chi M; Deng N; An J
    JMIR Mhealth Uhealth; 2020 Feb; 8(2):e14466. PubMed ID: 32130161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and Acceptability of mHealth Interventions for Managing Hyperphosphatemia in Patients Undergoing Hemodialysis.
    St-Jules DE; Woolf K; Goldfarb DS; Pompeii ML; Li H; Wang C; Mattoo A; Marcum ZA; Sevick MA
    J Ren Nutr; 2021 Jul; 31(4):403-410. PubMed ID: 33160812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pilot Study of OkKidney, a Phosphate Counting Application in Patients on Peritoneal Dialysis.
    Imtiaz R; Atkinson K; Guerinet J; Wilson K; Leidecker J; Zimmerman D
    Perit Dial Int; 2017; 37(6):613-618. PubMed ID: 28970367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.